Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic Leukemia

NCT00537030

Conditions
Adult Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia, Hematologic Diseases, +10 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Completed

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

NCT00910910

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • California Cancer Associates for Research and Excellence cCARE Escondido, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
View all 165 locations
View Trial Details
Completed

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

NCT01142674

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • St Louis Washington University St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View all 76 locations
View Trial Details
Completed

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

NCT00874211

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +45 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
View all 453 locations
View Trial Details
Completed

POEMS Syndrome Treatment With Lenalidomide

NCT01639898

Conditions
Abnormalities, Multiple, Blood Protein Disorders, Congenital Abnormalities, +11 more
Locations
  • CHU d'Angers Angers, France
  • CHU de Caen Caen, France
  • CHU de Lille Lille, France
  • CHU de Limoges Limoges, France
View Trial Details

Related conditions